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Kaposi sarcoma (KS), an angioproliferative disease
associated with Kaposi sarcoma herpesvirus (KSHV)
infection, harbors a diversity of cell types ranging
from endothelial to mesenchymal cells of unclear
origin. We developed a three-dimensional cell model
for KSHV infection and used it to demonstrate that
KSHV induces transcriptional reprogramming of
lymphatic endothelial cells to mesenchymal cells
via endothelial-to-mesenchymal transition (EndMT).
KSHV-induced EndMT was initiated by the viral
proteins vFLIP and vGPCR through Notch pathway
activation, leading to gainofmembrane-type-1matrix
metalloproteinase (MT1-MMP)-dependent invasive
properties and concomitant changes in viral gene
expression. Mesenchymal markers and MT1-MMP
were found codistributed with a KSHV marker in the
samecells fromprimaryKSbiopsies.Ourdataexplain
the heterogeneity of cell types within KS lesions and
suggest that KSHV-induced EndMT may contribute
to KS development by giving rise to infected, invasive
cells while providing the virus a permissive cellular
microenvironment for efficient spread.
INTRODUCTION
Kaposi’s sarcoma herpesvirus (KSHV) is the etiological agent for
Kaposi’s sarcoma (KS), an angioproliferative disease character-
ized by a prominent compartment of spindle cells that are
considered to be the tumor cells of KS (Ganem, 2010). Despite
extensive studies, the origin of the cells characterizing the KSCell Host &lesion is not established as the tumors are composed of quite
heterogenic populations of cells expressing markers of endothe-
lial cells (ECs) (Dupin et al., 1999; Kaaya et al., 1995), smooth
muscle cells, and fibroblasts (Kaaya et al., 1995; Stu¨rzl et al.,
1995;Weich et al., 1991). The prevailing view is that KS is derived
from endothelial cells (Ganem, 2010). KSHV infects various types
of ECs in culture, and they represent a useful model system for
studies on KSHV pathogenesis (McAllister and Moses, 2007).
Despite the apparent susceptibility of ECs, and especially
lymphatic ECs (LECs) to KSHV infection, primary ECs infected
with wild-type KSHV do not readily acquire properties of trans-
formed cells, and tend to lose the viral episomes upon culturing
(Grundhoff and Ganem, 2004). We and others have shown that
KSHV infection evokes antiproliferative, rather than proliferative,
responses in cultured ECs (Koopal et al., 2007; Lagunoff et al.,
2002), making aspects of KS tumorigenesis difficult to study
in vitro. Interestingly, growth suppression induced by recombi-
nant KSHV in endothelial precursor cells could be overcome
by implantation of the cells intomice, which resulted in the devel-
opment of KS-like tumors (Mutlu et al., 2007). This suggests that
the tumorigenic potential of KSHV is dependent on the tissue
microenvironment. Since crosslinked three-dimensional (3D)
matrices can mimic certain important aspects of the tissue envi-
ronment (Rowe and Weiss, 2009), we sought to identify cellular
pathways and virus-host interactions involved in KSHV patho-
genesis by using a 3D, organotypic model for KSHV-infected
primary LECs.RESULTS
Mesenchymal Cells in KS Lesions Are Infected
with KSHV
Spindle cells with heterogeneous mesenchymal marker ex-
pression of unclear origin have been reported in KS lesionsMicrobe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc. 577
Figure 1. Mesenchymal Cells in Primary KS
Tumors Are Infected with KSHV
Codistribution of LANA (punctate green signal)
and aSMA (red; left panels), LANA (punctate red
signal) and vimentin (green; middle panels), and
LANA (punctate red signal) and PDGFR-a (green;
right panels) in the same cells in sections of
nodular KS biopsies fromHIV-positive (A) andHIV-
negative (B) patients, as well as in a KS lymph
node involvement from an HIV-negative patient
(C). Nuclei were counterstained with Hoechst
33342 (blue). Scale bars represent 25 mm. See also
Figure S1 and Table S1.
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Mesenchymal Reprogramming by KSHV(Kaaya et al., 1995; Stu¨rzl et al., 1995; Weich et al., 1991). To
define the KSHV-infection status of these mesenchymal cells,
we double-labeled human KS biopsies for the KSHV latency
associated nuclear antigen (LANA) and mesenchymal markers
(a-smooth muscle actin [aSMA], vimentin, and PDGFR-a). The
KSHV-infected cells were distinguished by the typical punctate
staining of LANA in the cell nucleus. Cells coexpressing aSMA
and LANA were found in 10 out of 14 of the primary tumors
from HIV-positive or HIV-negative patients and in a lymph
node involvement of KS (Figure 1 and Figure S1 available on-
line). Based on a quantitative image analysis the overall per-
centage of cells showing codistribution of LANA and aSMA
was relatively low (Table S1). Interestingly, most of these cells
localized close to the interface of the tumor and the stroma
(Figures S1E and S1F). Cells double positive for LANA and
fibrous vimentin were detected in all of the KS biopsies
(14/14) and in the single lymph node involvement analyzed
(Figure 1 and Figure S1). Furthermore, seven out of eight
tumors contained cells positive for both PDGFR-a and LANA
(Figures 1A and 1B and Figure S1A, S1B, S1D, and S1E).
Whereas vimentin was observed also in LANA-negative, nonin-
fected cells, the LANA-positive cells displayed a stronger,
fibrous vimentin signal (Table S1 and Figure S1G). The unin-
fected, vimentin-expressing cells within tumors may represent
activated stromal fibroblasts or infiltrating lymphocytes. These
findings indicate that a substantial amount of the cells with
mesenchymal marker expression in KS lesions are KSHV
positive.578 Cell Host & Microbe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc.KSHV Induces Endothelial-to-
Mesenchymal Transition
in LEC Spheroids
KSHV induces reprogramming of blood
ECs (BECs) to LECs (and vice versa) in
two-dimensional (2D) cultures. Further-
more, the KS gene expression signature
resembles more that of LECs than BECs
(Carroll et al., 2004; Hong et al., 2004;
Wang et al., 2004). To investigate whether
KSHV infection could induce reprogram-
ming of ECs to the mesenchymal cells
that we observed in the KS lesions, we in-
fected differentiated, primary LECs with
KSHV, and established a 3D cell model
to provide a more physiological environ-
ment for the cells. The 3D organotypicculture is based on the property of ECs to form spheroids under
nonadherent conditions (Korff and Augustin, 1998), and it has
proven useful for studies on endothelial capillary sprouting.
Spheroids were prepared from KSHV-infected LECs (K-LECs)
and uninfected control LECs seven to ten days after infection
and monitored for 5 days. KSHV induced a dramatic outgrowth
of fibroblast-like cells in the LEC spheroids whereas minimal
sprouting was observed in control LECs (Figure 2A and Fig-
ure S2A). Although a little outgrowth of sprouts was occasionally
observed in the control LEC spheroids, these were tube-like
structures with the expression of PECAM-1 in the cell-cell junc-
tions typical for endothelial capillaries (Figure S2B).
Expression of mesenchymal proteins (aSMA, transgelin,
N-cadherin, fibronectin, and fibrous vimentin) was strongly in-
duced in the sprouts (but less so in the body) of the K-LEC
spheroids, but not in LEC control spheroids (Figure 2B). The up-
regulation of TAGLN, VIM, and CDH2, as well as a panel of other
mesenchymal markers (CNN1, PDGFRB,COL1A1, and S100A4)
was confirmed by quantitative reverse-transcriptase PCR (qRT-
PCR; Figure 2C). Importantly, none of these markers were
induced in the parental 2D K-LECs (Figure 2C), suggesting that
the 3D environment triggered the transition of K-LECs into a
mesenchymal phenotype.
To determine whether induction of mesenchymal markers in
the K-LEC spheroids was associated with changes in the EC
state, we detected EC markers in the spheroids. In accordance
with previous reports showing KSHV-induced downregulation
of EC markers in 2D (Mansouri et al., 2006; Qian et al.,
Figure 2. KSHV Induces Primary LECs to
Undergo EndMT in 3D
(A) Sprouting time course of LEC and K-LEC
spheroids after embedding into 3D.
(B) Expression of aSMA, transgelin, vimentin (in
red), N-cadherin, and fibronectin (in green) in LEC
and K-LEC spheroids.
(C) qRT-PCR analysis of transcripts for the indi-
cated mesenchymal genes in LEC and K-LEC
spheroids (3D) and their parental 2D cultures. Error
bars represent mean fold change with respect to
LEC ± SD; n = 2–4.
(D) Expression of PECAM-1 (in green) and ZO-1 (in
red) in LEC and K-LEC spheroids.
The nuclei in (B) and (D) were counterstained with
Hoechst 33342 (blue). Scale bars in (A), (B), and (D)
represent 50 mm. See also Figure S2.
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Mesenchymal Reprogramming by KSHV2008), EC marker (VE-cadherin) and LEC markers (VEGFR3
and LYVE1) were downregulated in the 2D K-LECs (Fig-
ure S2C). Futhermore, PECAM-1, a ubiquitous EC protein
and two LEC markers (VEGFR3 and podoplanin) were notably
downregulated in the mesenchymal marker expressing K-LEC
sprouts (Figure 2D and Figure S2D) with a simultaneous induc-
tion of fibronectin in the sprouts and at the outer rim of the
spheroid body of the K-LECs (Figure S2D). LEC marker down-Cell Host & Microbe 10, 577–590, Dregulation was further confirmed by qRT-
PCR for PROX1 and FLT4 (VEGFR3)
genes both in 2D and 3D K-LECs
(Figure S2E).
These data strongly suggest that in the
3D environment KSHV infection not only
suppresses expression of LEC markers,
but can also induce LECs to differen-
tiate into a new, mesenchymal cell type
via endothelial-to-mesenchymal transi-
tion (EndMT) (Potenta et al., 2008). This
process of cellular plasticity is analogous
to epithelial-to-mesenchymal transition
(EMT) with a recently proposed role in
tumor progression and metastasis and
as a source for cancer-associated fibro-
blasts and multipotent stem cells (Kalluri
and Weinberg, 2009). As a further con-
firmation of EndMT and loss of polarity,
we observed a clear relocalization of the
tight-junction protein ZO-1 from the cell-
cell contacts in control LEC spheroids
to more disperse, cytoplasmic localiza-
tion in the sprouts of K-LEC spheroids
(Figure 2D).
KSHV-Infection Is Required for
Extensive Sprouting of LECs in 3D
To test whether the K-LEC sprouting
required infectious virus, we formed
spheroids of LECs infected with UV-inac-
tivated virus (UV-K-LEC). Whereas the
control K-LEC spheroids sprouted effi-ciently, minimal sprouting was observed in the UV-K-LEC spher-
oids (Figures 3A and 3B). This suggests that infectious KSHV
rather than viral surface proteins or factors originating from the
virus preparation is required for sprout outgrowth. To define
the contribution of infected cells in sprout formation, spher-
oids were prepared from a 1:3 mixture of GFP-expressing
rKSHV.219-infected LECs and control LECs. GFP was observed
in most of the sprouts suggesting that infected cells wereecember 15, 2011 ª2011 Elsevier Inc. 579
Figure 3. KSHV-Induced EndMT Requires Infectious Virus and Is Positively Regulated by Notch but Inhibited by VEGF Stimulation
(A) Phase-contrast images of spheroids prepared from K-LECs and LECs infected with UV-inactivated KSHV (UV-K-LEC).
(B) Loss of sprouting in UV-K-LEC spheroids normalized to K-LEC.
(C) Confocal images of uninfected and GFP-expressing rK-LECs mixed in a 3:1 ratio to form spheroids.
(D) Confocal image of K-LEC spheroid stained with anti-LANA antibodies (green punctate nuclear signal). Dashed line denotes the spheroid body area and
arrowheads point examples of LANA-positive cells in the sprouts.
(E) Sprouting of LEC and K-LEC spheroids treated with DAPT or SB431542 (SB) compared to the corresponding vehicle K-LEC controls (ctrl).
(F) qRT-PCR analysis for the Notch downstream target genes HES1, HEY1 and the indicated mesenchymal markers in K-LEC spheroids in relation to vehicle
K-LEC control (mock).
(G) Sprouting and expression of mesenchymal markers (aSMA in red, and fibronectin in green) and the endothelial marker (PECAM in green) of the spheroids
prepared from mock-, VEGF-A-, or VEGF-C-stimulated K-LECs.
± SEM is shown; n = 2 (B, E, [SB], and F) and n = 3 (E [DAPT]). *p < 0.05, **p < 0.01, ***p < 0.001 (B, D, and F). Nuclei in (C), (D), and (G) were counterstained with
Hoechst 33342 (blue). Scale bars represent 100 mm (A and G) and 50 mm (C and D). See also Figure S3.
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Mesenchymal Reprogramming by KSHVpredominantly contributing to the sprouting (Figure 3C). In
addition, majority of the sprouting cells in 3D KLEC cultures
expressed KSHV LANA in majority of the sprouting cells
(Figure 3D).580 Cell Host & Microbe 10, 577–590, December 15, 2011 ª2011 ElsNotch Pathway Activation Initiates the KSHV-Induced
EndMT
EndMT induction has been described in response to activation of
the TGF-b or Notch pathways (Medici et al., 2010; Noseda et al.,evier Inc.
Cell Host & Microbe
Mesenchymal Reprogramming by KSHV2004; Timmerman et al., 2004). To elucidate the signaling path-
ways involved in the KSHV-induced EndMT, the spheroids
were treated with the inhibitor of TGF-b downstream kinases
ALK4, ALK5, ALK7 (SB431542), or an inhibiting antibody for
TGF-b (anti-TGF-b) upon embedding in fibrin, while the Notch
pathway was inhibited using a gamma-secretase inhibitor
(DAPT) or a soluble inhibitor of Dll4/Notch signaling (Dll4-Fc).
SB431542 (Figure 3E) or anti-TGF-b (data not shown) did not
inhibit sprouting of the K-LEC spheroids or affect the phenotype
of control LEC spheroids. KSHV infection alone did not signifi-
cantly induce any of the tested TGF-b targets (PAI-1, CTGF,
SNAI1, and ZEB1) in LECs. Although K-LECs were responsive
to TGF-b stimulation (Figure S3B) it did not significantly affect
sprouting or the expression of Notch and the mesenchymal
transcripts in the K-LEC spheroids (Figures S3A and S3B).
Induction of all the TGF-b target genes were effectively inhibited
by SB431542 in the TGF-b stimulated samples whereas expres-
sion of HES1 and mesenchymal transcripts remained essentially
unchanged (Figure S3C).
In contrast, inhibition of the Notch pathway by DAPT or Dll4-
Fc dramatically reduced the number of sprouts in the K-LEC
spheroids (4- and 7.5-fold, respectively; Figure 3E and Fig-
ure S3D), whereas control LEC spheroids were unaffected.
Transcripts for mesenchymal markers such as TAGLN (5.6-
fold), PDGFRB (2.5-fold), VIM (2.4-fold), and CDH2 (2.5-
fold) were decreased accordingly in the DAPT-treated (Fig-
ure 3F) and Dll4-Fc-treated K-LEC spheroids (Figure S3E).
The involvement of Notch is in line with recent reports dem-
onstrating engagement of Notch signaling in LECs by KSHV
(Emuss et al., 2009; Liu et al., 2010). Consistently, the down-
stream targets of the activated Notch, HEY1 and HES1 were
induced in K-LECs cultured in both 2D and 3D (data not
shown). Taken together, our data suggest that Notch sig-
naling is a major positive regulator of the KSHV-induced
EndMT in 3D.
KSHV-Induced EndMT and VEGF-Stimulated
Lymphangiogenesis Represent Distinct Biological
Processes
Notch signaling has previously been shown to antagonize
vascular endothelial growth factor (VEGF) function and to in-
hibit angiogenic sprouting of HUVECs (BECs) (Ridgway et al.,
2006) and lymphangiogenic sprouting of LECs (Zheng et al.,
2011) in assays similar to our system. Thus, we compared
sprouting of mock-treated K-LEC spheroids to K-LEC spher-
oids stimulated by VEGF-A or VEGF-C. Light-microscopic
analysis revealed outgrowth of the typical mesenchymal-like
sprouts from the mock spheroids, whereas both of the
VEGF-A or -C stimulated spheroids showed extensive sprout-
ing with apparent capillary morphology (Figure 3G). Confocal
microscopy and qRT-PCR analysis further demonstrated that
in contrast to the mock, the sprouts in the VEGF-A/C-stimu-
lated spheroids did not express mesenchymal markers
(aSMA, fibronectin) but had a strong signal for the EC marker
PECAM (Figure 3G and data not shown). These results indicate
that the KSHV-induced mesenchymal reprogramming of LECs
in 3D is a unique process induced and regulated by different
biological stimuli than the (lymph)angiogenic sprouting by
VEGF-A/C.Cell Host &vGPCR and vFLIP Are Involved in the Reprogramming of
LECs
Two KSHV encoded proteins were recently shown to engage
Notch signaling; the viral FLICE inhibitory protein (vFLIP) through
induction of JAG1 and the viral G protein-coupled receptor
(vGPCR) through upregulation of DLL4 (Emuss et al., 2009). To
investigate whether these viral genes were involved in the
KSHV-induced EndMT, LECs were transduced with lentiviruses
expressing vGPCR, vFLIP, and an empty control virus (pSIN).
As revealed by phase contrast and IF confocal microscopy,
vGPCR- and vFLIP-expression in the spheroids induced aSMA
and vimentin expressing sprouts (Figure 4A). Accordingly, upre-
gulation of HES1, HEY1, and mesenchymal markers TAGLN,
VIM, and CDH2 was seen by qRT-PCR in the vGPCR- and
vFLIP-spheroids over the pSIN-spheroids (Figure 4B). Inhibition
of Notch by DAPT reduced sprouting of the vGPCR-expressing
spheroids by 2-fold (Figure 4C) and induction of the indicated
mesenchymal transcripts by 2.1- to 2.7-fold (Figure 4D). DAPT
treatment of the vFLIP-expressing spheroids resulted in amilder,
but significant decrease both in sprouting (1.3-fold; Figure 4C)
and induction of most of the mesenchymal markers (1.4- to
2.0-fold; Figure 4D). This suggests that vFLIP and vGPCR are
involved in the activation of KSHV-induced EndMT via Notch. In
contrast, lenti- or retroviral expression of the latent genes LANA
or v-cyclin, respectively, did not induce sprouting (Figure 4E) or
expression of the Notch targets (SNAI2 andNRARP) andmesen-
chymalmarkers in the primary LECs (Figure S4A), although LANA
has also been implicated in Notch activation (Liu et al., 2010).
To assess the requirement of vFLIP and vGPCR in EndMT in
the context of the whole virus infection, we silenced the expres-
sion of vFLIP and vGPCR individually or simultaneously in
K-LECs. Sprouting of the K-LEC spheroids was reduced for
42% by depletion of vGPCR, for about 36% by vFLIP depletion
and for 57% by simultaneous silencing of them both (Figure 4F),
which was coupled with the reduction of aSMA and fibronectin
expression in the corresponding K-LEC spheroids (Figure 4G).
These results indicate that vGPCR and vFLIP coregulate the
EndMT in K-LECs.
Cytoskeletal Dynamics Is Essential
for the Virus-Induced EndMT in 3D
To testwhether sprouting is aprerequisite for theEndMT in the3D
microenvironment, we treated K-LEC spheroids with chemicals
disrupting either microtubules (nocodazole) or actin filaments
(cytochalasin D). Nocodazole disrupted the fibroblast-like mor-
phology of the sprouts in K-LEC spheroids (Figure S4B) and abol-
ished induction of mesenchymal gene expression, whereas the
downstream targets of Notch signaling were unaffected or
slightly increased (Figure S4C). As cytochalasin D treatment led
to a significant decrease in both Notch signaling and mesen-
chymal marker expression (data not shown), we were unable to
differentiate its specific effect on EndMT. These data suggest
that a functional microtubule network (cooperating with the
Notch pathway) is essential for the KSHV-induced EndMT.
KSHV-Induced EndMT Endows Primary LECs with
Invasive Properties
To obtain a more comprehensive picture of the properties of 3D
reprogrammed K-LECs, we compared the gene expressionMicrobe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc. 581
Figure 4. Notch Engagement by vGPCR and
vFLIP Is Involved in the KSHV-Induced
EndMT
(A) Expression of aSMA (middle panels, in red) and
vimentin (right panels, in red) proteins in pSIN-,
vGPCR-, and vFLIP-transduced LEC spheroids.
Phase contrast images are shown on the left.
(B) Expression of HES1, HEY1 and the indicated
mesenchymal transcripts in the spheroids de-
scribed in (A).
(C) Sprouting of vGPCR- and vFLIP-transduced
LEC spheroids treated with DAPT (+) over the
vehicle control (–).
(D) Expression of HES1, HEY1 and indicated
mesenchymal genes in the vehicle- (mock) or
DAPT-treated vGPCR- and vFLIP-transduced
LEC spheroids.
(E) Sprouting of LECs expressing LANA or v-cyclin
and their individual control vectors (mock).
(F) Sprouting of K-LEC spheroids four days
after silencing of vGPCR and vFLIP using control
siRNAs (si-ctrl), specific siRNAs for vGPCR (si-
vGPCR) or vFLIP (si-vFLIP) individually, or simul-
taneously (si-vGPCR+si-vFLIP). Error bars repre-
sent the means of experiments with two different
siRNA constructs per condition.
(G) Representative confocal images of the ex-
pression of aSMA (upper panels, in red) and fi-
bronectin (lower panels, in green) in K-LEC
spheroids in (F).
Scale bars represent 200 mm (A and E), and
100 mm (G). In (A) and (G), nuclei were counter-
stained with Hoechst 33342 (blue). Error bars in all
panels represent the mean fold change with re-
spect to the corresponding mock-treated, vector,
or control siRNA controls ± SEM; n = 2 (C [vFLIP]
and F), n = 3 (C [vGPCR] and D), and n = 2–4 (B).
*p < 0.05, **p < 0.01, ***p < 0.001 (B–D and F). See
also Figure S4.
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Mesenchymal Reprogramming by KSHVmicroarray (GEM) profiles of K-LEC spheroids to control LEC
spheroids 3 days after embedding to fibrin. The 3D K-LEC tran-
scriptome showed significant upregulation of invasion related
genes (GSEA analysis, q = 0.106, FWER p value < 0.0001). The
genes with significant change in expression (p < 0.05) are
shown in Figure 5A. These included genes for proteases PLAU,
CTSK, ADAMTS1, and MMP1, invasion-linked signaling pro-
teins SPP1, PDGFRA, CXCL2, and CXCR4, and transcription
factors ETS2, FOXF1, and FOXF2 implicated in EMT and inva-
sion, a subset of which has been validated by qRT-PCR
(Figure 5B).
To assess the biological relevance of our 3D system to KS, we
next compared the K-LEC 3D transcriptome to gene expression
profiles of KS biopsies and 2D K-LECs (Wang et al., 2004). This
analysis revealed a number of genes coregulated in all three-
sample groups (Figure S5A). Intriguingly, the genes with similar582 Cell Host & Microbe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc.coregulation in our system (3D) and KS
biopsies included genes involved both in
EMT/EndMT and invasive processes
(Figure S5B).
As the data suggests that the K-LECs
had acquired invasive properties uponreprogramming, and matrix metalloproteinases (MMPs) are
key enzymes in cancer cell invasion, we inhibited MMPs in
LEC and K-LEC spheroids. A broad-spectrum MMP inhibitor
GM6001 significantly reduced the sprouting of K-LEC spheroids
(Figure 5C), supporting the necessity of MMPs in sprouting. To
assess whether soluble or membrane-associated MMPs were
required, we examined the effects of tissue inhibitors of metallo-
proteinases, TIMP1 and TIMP2. TIMP1 inhibits the secreted,
soluble MMPs, including MMP1, MMP2, and MMP9, while
TIMP2 widely reduces activity of both soluble MMPs and
membrane-boundMT-MMPs (Baker et al., 2002).Whereas treat-
ment with TIMP1 had no effect on the K-LEC spheroids, TIMP2
dramatically inhibited sprouting (Figure 5C), suggesting the
involvement of MT-MMPs in the sprouting. Accordingly, a strong
upregulation of MMP14 (gene for MT1-MMP), but not MMP15
(gene for MT2-MMP) or MMP16 (gene for MT3-MMP), was
Cell Host & Microbe
Mesenchymal Reprogramming by KSHVobserved in 3D K-LECs by qRT-PCR (Figure S5C). Increased
MT1-MMP was also detected by IF of the K-LEC spheroids
(Figure S5D).
To functionally assess the invasive properties of LEC and
K-LEC cells, we performed an MT-MMP-dependent invasion
assay through a crosslinked collagen matrix (Rowe and Weiss,
2009). The results indicate that uninfected LECs lack invasive
capacity (0.3 invading cells per field), whereas K-LECs are
able to invade collagen (approximately nine invading cells per
field, p < 0.001; Figure 5D). These results further suggest that
KSHV-induced EndMT involves MT1-MMP-dependent invasive-
ness. Interestingly, intense MT1-MMP signal was detected
predominantly in the KSHV-infected cells (LANA positive) within
most of the sections of nodular KS biopsies from one HIV-posi-
tive and five HIV-negative patients, whereas it was barely detect-
able in the surrounding stroma (Figure 5E and Figure S5E).
Notably, MT1-MMP was also detected in individual, apparently
invasive KSHV-infected cells observed within the surrounding
stromal tissue (Figure 5E, arrowheads).
Notch Signaling Induces the 3D K-LECs to Undergo
EndMT through MT1-MMP
To further define the requirement of MT1-MMP in EndMT, we
depleted MT1-MMP from K-LEC and LEC spheroids (Figure 5F).
Depletion of MT1-MMP by two different small interfering RNAs
(siRNAs) reduced the sprouting by 2.0- and 2.2-fold respec-
tively (Figure 5F), indicating thatMT1-MMP is required for efficient
K-LEC sprouting in 3D fibrin, and may represent the major MMP
involved. MT1-MMP depletion had only a minor effect on expres-
sionofNotch target genesHES1andHEY1, but led toan3.3-fold
decrease in expression of the mesenchymal marker transgelin
(Figure 6A) in the K-LEC spheroids. Interestingly, depletion of
MT1-MMP also diminished expression of the PDGFRB gene
(2.6-fold; Figure 6A), which is a known effector of EMT (Jechlin-
ger et al., 2006) and cell invasion in fibrin (Lehti et al., 2005). In
contrast, treatment of K-LECs with DAPT and Dll4-Fc abolished
the induction of MT1-MMP both in 2D and 3D (Figure 6B and
data not shown) as well as the 3D-specific induction of PDGFRB
and TGLN (see Figure 3F for DAPT and Figure S3E for Dll4-Fc).
These results suggest thatMT1-MMP acts downstreamof Notch,
but is required in 3D for the induction of KSHV-induced EndMT.
To assess further the effects expression of MT1-MMP on
the LEC phenotype, we retrovirally overexpressed GFP-tagged
MT1-MMP in 3D LECs. Expression of MT1-MMP was confirmed
by qRT-PCR (Figure 6C; MMP14) and GFP expression (Fig-
ure S5F). Outgrowth of sprouts with aSMA expression was
seen in the MT1-MMP-expressing LEC spheroids, but not in the
mock control (Figure S5F; LEC). Importantly, MT1-MMP expres-
sion induced a panel of mesenchymal transcripts including
PDGFRB, which was abolished by GM6001 (Figure 6C). MT1-
MMP did not significantly alter the expression of the Notch target
genes, confirming that it acts downstream of Notch and is suffi-
cient to induce LEC invasion and EndMT. These results identify
the Notch pathway as a previously unrecognized regulator of
MT1-MMP in the sprouting and EndMT in 3D LECs.
Contribution of 3D-Induced PDGFR-b on EndMT
To address the potential role of PDGFR-b in the KSHV-EndMT
we inhibited its kinase activity with the reported PDGFR-bCell Host &inhibitor SU16f (Sun et al., 1999). SU16f treatment led to reduced
sprouting in the K-LEC spheroids (Figure S6A) and reduced the
expression of mesenchymal markers TAGLN, VIM, and CDH2
as well as that of MMP14, PDGFRB and Notch target gene
HEY1 in K-LEC spheroids (Figure S6B). To assess more specif-
ically the contribution of PDGFR-b in the EndMT we silenced
its expression by RNA interference. Unexpectedly, efficient
depletion of PDGFR-b led to only a moderate, yet significant
reduction in spheroid sprouting and mesenchymal marker ex-
pression (Figures 6D and 6E). As the related receptor PDGFR-a
is also significantly upregulated in the 3D K-LECs, we sought to
determine whether the inhibitor would also target PDGFR-a.
Consistent with the results reported by Sun et al. (1999), SU16f
dramatically decreased PDGFR-a autophosphorylation in a
fibroblast cell line (WI38) with prominent expression of PDGFR-a
(Figure S6C). To gain further insight into the role of PDGFR-a in
the KSHV-EndMT, we silenced its expression alone or in combi-
nation with PDGFR-b. However, depletion of PDGFR-a alone did
not affect sprouting, and simultaneous silencing with PDGFR-b
did not lead to stronger inhibition on sprouting than PDGFR-b
silencing alone (Figure S6D), suggesting that PDGFR-b, but not
PDGFR-a, contributes to the KSHV-EndMT (Figure 6F).
3D Microenvironment Leads to Changes in Viral Gene
Expression of K-LECs
To investigate whether the microenvironment of the 3D culture
and KSHV-induced EndMT involved changes in the pattern of
viral gene expression, we carried out qRT-PCR analyses for
the expression of latent, early and late lytic transcripts in parental
2D and 3D K-LECs at different time points. By comparison of the
mean fold changes of expression between 3D and 2D K-LECs,
time-dependent increase in the messenger RNA (mRNA) levels
of the latent and lytic viral genes was observed in the 3D cultured
K-LECs (Figure 7A). Of note, the mRNA levels of these genes
were 2.9- to 8.5-fold increased in 3D over 2D even before
embedding the spheroids in fibrin (Figure S7A; day 0), suggest-
ing that the microenvironment during spheroid formation in the
non-adherent condition already induces substantial differences
in the viral gene expression. Accordingly, a clearly higher propor-
tion of cells expressed the early lytic protein ORF59 in the K-LEC
spheroids when compared to the parental K-LECs in 2D and
increased over time in 3D culture (Figure 7B). Intriguingly, and
in accordance with the increase in LANA mRNA levels in the
3D K-LECs, the majority of the infected cells in K-LEC spheroids
(90%) displayed a significantly higher number of nuclear punc-
tate LANA signal by IF (more than ten dots per cell) compared
to the parental, infected K-LECs cultured in 2D (about 16%; Fig-
ure 7C and Figure S7B). In addition, a time-dependent increase
in the viral DNA levels in 3D K-LECs over 2D cells was observed
in a real time qPCR analysis on genomic DNA extracted from
matching same-day cultures of the cells (Figure S7C).
In a good agreement with their role in KSHV-induced EndMT,
both vFLIP and vGPCR transcript levels are elevated in the 3D
K-LECs. As Notch has been shown to regulate viral lytic infection
via functional interaction with CSL (Liang and Ganem, 2003) we
compared expression of a panel of lytic transcripts and the latent
LANA mRNA in 3D K-LECs in the presence and absence of
DAPT. Although DAPT treatment led to a decrease in the expres-
sion of ORF50 and some late lytic genes (vIRF-2, ORF25, andMicrobe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc. 583
Figure 5. KSHV Endows Primary LECs with MT1-MMP-Dependent Invasive Properties
(A) Heat map representing the most significant relative changes in gene expression of invasion-related genes in 3D LECs after KSHV infection (all probe sets
shown, p < 0.05). Red and blue denote high and low expression, respectively.
(B) qRT-PCR analysis of mRNA levels for the indicated transcripts in the LEC and K-LEC spheroids.
(C) Inhibition of sprouting of K-LEC and LEC spheroids treated with inhibitors for MMPs (GM6001, TIMP1, and TIMP2) and the respective vehicle controls (mock).
(D) Invasion of control LECs and K-LECs into a 3D collagenmatrix. H&E staining of the collagen matrix (left panels; scale bars represent 50 mm) and quantification
of the collagen-invading cells (right panel). Arrowhead indicates an invading cell.
(E) Colocalization of LANA (green) and MT1-MMP (red) in a nodular KS biopsy from a HIV-negative patient. Nuclei were counterstained with Hoechst 33342
(blue). The scale bar represents 50 mm. Dashed line denotes the edge of the tumor tissue, and the arrowheads indicate cells invading into the surrounding normal
tissue.
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Figure 6. Interplay of Notch,MT1-MMP, and
PDGFR-b in the KSHV-Induced EndMT
(A) qRT-PCR analysis for the expression of indi-
cated genes in K-LEC spheroids after depletion of
MT1-MMP with specific siRNA oligos (si1-MT1-
MMP and si2-MT1-MMP) or control siRNA.
(B) qRT-PCR analysis of mRNA levels of MT1-
MMP in K-LEC vehicle- (K-LEC mock) or DAPT-
treated (K-LEC DAPT) spheroids.
(C) qRT-PCR analysis for Notch target genes and
indicated mesenchymal genes in spheroids of
MT1-MMP expressing LECs (MT1-MMP-LEC) or
mock-LECs in the presence of GM6001 or the
vehicle (DMSO).
(D) Sprouting of the K-LEC spheroids four days
after silencing PDGFR-b with specific siRNA oli-
gos (si PDGFR-b) or control siRNA.
(E) qRT-PCR analysis for indicated genes in the
K-LEC spheroids after depletion of PDGFR-b as
described in D.
(F) Schematic model for the interplay between the
Notch, MT1-MMP, and PDGFR-b in the KSHV-
induced reprogramming and EndMT.
Error bars in all panels represent the mean fold
change with respect to the corresponding mock-
treated (B andC), vector, or control siRNA controls
(A, D, and E). ± SEM is shown; n = 2 (A–C and E)
and n = 3 (D). *p < 0.05, **p < 0.01, ***p < 0.001
(A–E). See also Figure S6.
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or vIL-6 (Figure S7D). To assess the possibility that the late lytic
genes would be involved in inducing EndMT, we inhibited their
expression, using a well-known inhibitor of lytic replication gan-
ciclovir (GCV) (Kedes and Ganem, 1997). However, this had no(F) Top: Inhibition of sprouting of K-LEC and LEC spheroids by silencing MT1-MMP with specific siRNA o
Western blot analysis with anti-MT1-MMP antibodies.
Error bars in all panels represent mean fold changewith respect to the corresponding control (LEC in B andD;m
n = 4–5; in (C), ± SD is shown, n = 2–4; in (D), ± SD is shown, n = 2, and in (F), ± SEM is shown, n = 2–3. *p <
Figure S5.
Cell Host & Microbe 10, 577–590, Deffect on sprouting (data not shown)
or induction of the Notch target SNAI2
and mesenchymal transcripts (MMP14,
TGLN, and VIM) (Figure S7E).
To address whether the observed gene
expression changes involved alterations
in the epigenetic landscape of the viral
genome, we analyzed histone modifica-
tion patterns of viral episomes in cells
grown under 2D or 3D conditions. We
focused on the distribution of H3 mole-
cules that are trimethylated at lysine 4
(H3K4-me3), a modification that is com-
monly associated with open or active
chromatin. ChIP-on-chip analysis re-
vealed no fundamental differences in
the overall distribution profile of this his-
tone modification of the viral chromatin
between the K-LECs cultured under 3D
or 2D conditions at day three (Figure 7D).Both cultures display several prominent peaks that map to the
terminal repeat regions, the genomic segment spanning open
reading frames (ORFs) K2 to K7, as well as to regions that
encode Kaposin, the viral microRNAs, ORF72, ORF71 and the
latency promoter-proximal region of ORF73 (Figure 7D). It shouldligos (si1-MT1-MMP and si2-MT1-MMP). Bottom:
ock in C, and ctrl siRNA in F). In (B), ± SD is shown,
0.05, **p < 0.01, ***p < 0.001 (B–D and F). See also
ecember 15, 2011 ª2011 Elsevier Inc. 585
Figure 7. 3D Microenvironment Induces Changes in the Viral Gene Expression of K-LECs
(A) qRT-PCR analysis for the expression of latent KSHV genes LANA and vFLIP and lytic genes ORF50, vGPCR, vIL-6, vIRF-2, and K8.1 at three different time
points (day 0, 1, and 3). Error bars represent a mean fold change of expression in K-LEC 3D over 2D. The value for each gene in the 2D and 3D time points was
normalized to the corresponding day 0 values in 2D or 3D, respectively. ± SEM is shown; n = 3–5.
(B) Expression of the lytic protein ORF59 in the parental 2D (K-LEC 2D) and 3D K-LECs (K-LEC 3D) at three different time points (day 0, 1, and 3).
Cell Host & Microbe
Mesenchymal Reprogramming by KSHV
586 Cell Host & Microbe 10, 577–590, December 15, 2011 ª2011 Elsevier Inc.
Cell Host & Microbe
Mesenchymal Reprogramming by KSHVbe pointed out though that the peaks appear to be less promi-
nent in the 3D cultures (Figure 7D), a result that was also
confirmed by qRT-PCR (Figure 7E). However, since the principal
peak distribution of H4K4-m3 marks appears unaffected, we
conclude that global changes of H3K4-me3 marks are unlikely
to be responsible for the viral gene expression changes ob-
served between the 3D and 2D cultures. An interesting possibility
is that such changes may instead result from the loss of repres-
sive marks such as H3K27-me3. This histone modification has
previously been found to be present on latent KSHV episomes,
where it suppresses lytic gene expression via recruitment of
polycomb repressor complexes (Gu¨nther and Grundhoff, 2010;
Toth et al., 2010). A loss of H3K27-me3 would be expected to
result in increased gene expression from loci that are otherwise
in a transcription-competent state, e.g., those which carry acti-
vation marks such as H3K4-me3.
DISCUSSION
Here, we demonstrate that KSHV reprograms primary LECs to
mesenchymal cells via EndMT, suggesting that the heteroge-
neity of cell types in KS lesions could originate from the infected
endothelium via this process. The data further identifies Notch as
a previously unrecognized upstream regulator ofMT1-MMP, and
demonstrates that MT1-MMP is sufficient to provide LECs with
a mechanism to undergo EndMT in 3D. We also show induction
of PDGFR-b by the Notch MT1-MMP axis in the EndMT, which
concurs with an earlier report linking Notch 4-mediated upregu-
lation of PDGFR to EndMT (Noseda et al., 2004). Moreover,
culturing K-LECs in the 3D microenvironment led to intriguing
changes in the pattern of viral gene expression.
The Notch pathway has been implicated in both KSHV latency
(Lan et al., 2007) and lytic replication (Chang et al., 2005).
Accordingly, Notch 1–Notch 4 are reported to be expressed in
KS tumors (Curry et al., 2005). Consistent with previous reports
(Emuss et al., 2009; Liu et al., 2010), the KSHV-induced reprog-
ramming was initiated by the engagement of Notch pathway
already in 2D. However, the transition into mesenchymal pheno-
type required both a microenvironment provided here by the
crosslinked 3D fibrin matrix, and intact microtubule dynamics
to support the ingression into the 3D matrix. Contrary to our
data, induction of mural cell markers was recently reported in
2D cultured HPV-16 E6/E7-immortalized LECs stably infected
by rKSHV (Liu et al., 2010). This could be due to the sensitizing
effect of ectopic E6 and E7, as overexpression of these genes
has previously been implicated in EMT induction (Hellner et al.,
2009).
The consequence of Notch inhibition in our 3D system, i.e., the
significant attenuation of K-LEC sprouting and EndMT differs
significantly from the effect of Notch inhibition on blood ECs(C) Expression of LANA (green) in the parental 2D (2D) and 3D K-LEC (3D) cultures
(red). Insets show a magnification of the cell indicated with a white box. Arrowhe
(D and E) Global patterns of H3K4 tri-methylation (H3K4-me3) in parental 2D and 3
shown on the y axis represent enrichment of normalized signals obtainedwith an H
and genomemap shown at the bottom of each panel refer to the reference KSHV s
and gray boxes, respectively. Arrows in (D) indicate six genomic loci for which
enrichment of immunoprecipitated versus input levels for H3K27-me3 or negativ
In (B) and (C), nuclei were counterstained with Hoechst 33342 (blue). Scale bars re
Cell Host &and angiogenesis (Ridgway et al., 2006; Zheng et al., 2011).
Moreover, stimulation of K-LECs by VEGF-A/C induced a
dramatic outgrowth of capillary sprouts in 3D, and a simulta-
neous inhibition of EndMT. This suggests that the mesenchymal
sprouting of K-LECs represents a distinct biological process that
dominates over the (lymph)angiogenic sprouting in the absence
of VEGF-A/C stimulation. These results further corroborate the
central role of Notch signaling in cell-fate determination, and
as a critical determinant for the lymphangiogenic versus mesen-
chymal fate of LECs.
Our results reveal a 3D environment dependent function of
MT1-MMP as an EndMT inducer in LECs, which is consistent
with the ability of MT1-MMP to induce an invasive EMT program
in MCF7 cells in 3D environment, although the cells retain their
epithelial morphology in 2D culture. Although the mechanisms
by which MT1-MMP mediates such effects remain to be estab-
lished, it is important to bear in mind that MT1-MMP has
hundreds of potential extracellular matrix (ECM) and non-ECM
substrates (Butler et al., 2008). In the case of EMT or EndMT,
MT1-MMP-mediated proteolysis could also indirectly affect
gene expression by altering local ECM rigidity, cell shape, and
tension (Rowe and Weiss, 2009). Along these lines, MT1-MMP
also interacts with membrane receptors including integrins,
FGFRs, and PDGFRs, thus altering the receptor functions and
cell phenotype (Lehti et al., 2005; Sugiyama et al., 2010). In the
context of K-LECs, where KSHV-induced Notch activation first
upregulated MT1-MMP already in 2D KLECs, both MT1-MMP
itself and PDGFR-b were part of the transcriptional EndMT
program induced by Notch/MT1-MMP axis in 3D environment.
As a potent regulator of mesenchymal cell invasion, proliferation,
and differentiation, PDGFR-b cooperated as a logical partner
with MT1-MMP in EndMT.
Primary LECs normally express very low levels of MT-MMPs
(Petrova et al., 2002). Here, we demonstrate that KSHV reprog-
ramming induces a substantial MT1-MMP upregulation in the
KSHV-infected LECs, resulting in cell invasive activities in 3D
fibrin and collagen. This is in striking contrast to MT1-MMP
expression during angiogenesis where it is confined largely to
the tip cell of the sprouting neovessels (Yana et al., 2007). In
several human cancers MT1-MMP serves as a critical regulator
of both growth and dissemination of tumor cells (Rowe and
Weiss, 2009). We further identify MT1-MMP as a prominent
marker of KSHV-infected cells in KS tumors. MT1-MMP was
also expressed in the single LANA-positive, KSHV-infected cells
in the surrounding stromal tissue. They can represent infected
cells that mediate spreading and persistence of the infection
via invasion and dissemination from the primary site. In support
of this proposal, the K-LEC spheroids showed a time-dependent
increase in the number of the nuclear punctate LANA dots per
cell and amount of viral DNA over the parental 2D cultures,at day 3. Cells were double stained for the expression of the lytic protein ORF59
ads point to LANA-positive cells in the images.
D K-LEC cultures (D; upper and lower plots, respectively, in each panel). Values
3K4-me3 specific antibody relative to IgG isotype control. Nucleotide positions
equence (NC_009333). ORFs and repeat regions are indicated as block arrows
qRT-PCR analysis was done in (E) to confirm the array data as the observed
e control IgG. ± SEM is shown; n=2.
present 100 mm. *p < 0.05, **p < 0.01, ***p < 0.001 (A and E). See also Figure S7.
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for viral replication. The number of individual LANA dots per
cell has been shown to be predictive of intracellular viral genome
load (Adang et al., 2006). Therefore the apparently higher viral
load in the 3D K-LECs could be due to increased latent replica-
tion, improved maintenance of viral episomes or re-infection of
the cells as a result of activated lytic program upon change
from 2D to 3D microenvironment.
Taken together, our results suggest that Notch signaling is
activated in K-LECs by the KSHV proteins vGPCR and vFLIP,
which in turn leads to Notch-dependent induction of MT1-
MMP. Consistently, exogenous vGPCR expression has pre-
viously been linked to MT1-MMP upregulation in pulmonary
arterial endothelial cells (Shan et al., 2007). The activated Notch
and MT1-MMP were not sufficient for the virus-induced EndMT
in 2D, which required the crosslinked 3D fibrin matrix. Signals
provided by the 3D microenvironment led to a further increase
in MT1-MMP and induction of mesenchymal markers (see Fig-
ure 6F for a schematic model). In light of these findings, we
propose that the KSHV-induced invasive mesenchymal cell
phenotype could contribute to the development of KS, and
help to explain the progression of the disease through spread
of the infected cells into surrounding connective tissue.
EXPERIMENTAL PROCEDURES
Cell Lines and Cell Culture
The BCBL-1 cells were provided by A. Moses (Oregon Health and Science
University) or through the National Institutes of Health AIDS Research
and Reference Reagent Program (catalog number 3233 from McGrath and
Ganem), and cultured in RPMI 1640 medium supplemented with 10% fetal
calf serum (FCS; Invitrogen), 100 U/ml penicillin, and 100 mg/ml streptomycin.
Primary juvenile foreskin lymphatic endothelial cells (LECs; PromoCell) were
cultured in the basal EC medium plus supplements (PromoCell), in the pres-
ence of 5%human serum, 25 mg/ml amphotericin B, and 25 mg/ml gentamycin.
rKSHV-Vero cells (Vieira and O’Hearn, 2004) (a kind gift of J. Vieira, Uni-
versity of Washington), U2OS human osteosarcoma cell line (obtained from
the American Type Culture Collection [ATCC]), and WI-38 human embryonic
lung fibroblasts (ATCC CCL-75, obtained from ATCC) were cultured in Dul-
becco modified Eagle’s medium (DMEM) containing 10% FCS, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 5 mg/ml puromycin. All cells were
cultured in a humidified 5% CO2 atmosphere at 37
C.
KSHV Infection of LECs
For infection, the LECs were split at a density of 2.5 3 105 cells per a 6-well,
and spin-infected with multiplicity of infection (MOI) of 3 in serum-free
mediumwith 8 mg/ml polybrene. In the K-LEC cultures, the WT KSHV infection
efficiency was 20%–40% by LANA staining or 30%–50% with recombinant
rKSHV.219 by GFP expression. To produce inactivated virus (UV-KSHV), an
aliquot of freshly produced KSHV was treated by 3000 mJ of UV-C light with
UV Stratalinker 1800 (Stratagene), and the loss of infectivity was confirmed
by measurement of the virus titer.
Generation of LEC Spheroids
Confluent monolayers of spindling K-LECs or uninfected control LECs were
seeded into 0.5% agarose precoated, nonadherent round-bottom 96-well
plates at 4000 cells per well. After 16 hr to 24 hr incubation at 37C, the formed
spheroids were harvested and embedded into the fibrin gel consisting of plas-
minogen-free human fibrinogen (final concentration 3mg/ml; Calbiochem) and
human thrombin (final concentration 2 U/ml; Sigma) in 50 ml Hank’s Balanced
Salt Solution supplemented with 400 mg/ml aprotinin (Sigma). The gels were
cast onto the bottom of 24-well plates and incubated for 1 hr at 37C to allow
complete gelling followed by addition of EC culture medium and followed for
2–5 days.588 Cell Host & Microbe 10, 577–590, December 15, 2011 ª2011 ElsQuantification of Spheroid Sprouting
Quantification of spheroid sprouting was performed from the phase con-
trast images with the Inkscape software (http://www.inkscape.org/), and
then analyzed in a pipeline created in the Anduril framework (Ovaska et al.,
2010). For a detailed description of this, see the Supplemental Experimental
Procedures.
Chemicals and Treatments
The inhibitors and ligands used are described in the Supplemental
Experimental Procedures. Human VEGF-A and VEGF-C were included in the
medium 1 day before spheroid preparation, during spheroid formation, and
for 2 days in 3D. WI-38 cells were treated with PDGF-AA and PDGF-BB for
10 min after SU16f treatment for 24 hr to address the phosho-Tyrosine
(pTyr) signal by immunoprecipitation and immunoblotting. Unless stated
otherwise, the inhibitors were added into the medium after the spheroids
were embedded into the fibrin gel and followed for 2–4 days.
Invasion Assay
Collagen invasion was assessed essentially as described (Hotary et al.,
2000). For a detailed description of this, see the Supplemental Experimental
Procedures.
Statistical Analysis
For statistical evaluation of qRT-PCR data, the values (logarithmic) were con-
verted to ddCt values (linear log2 scale values) and p values were calculated
with a one-tailed unpaired Student’s t test. The p values for sprouting and inhi-
bition of gene expression were calculated directly from the data normalized to
the appropriate control.
Accession numbers
Microarraydataaredeposited inNCBIGEOunderaccessionnumberGSE22522
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=vxqvzoiuuqwaenw&
acc=GSE22522).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
doi:10.1016/j.chom.2011.10.011.
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